PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1977; 70(Suppl 3): 109–113.
PMCID: PMC1543578

Effect of penicillamine on the kidney.

Abstract

Twenty patients with rheumatoid arthritis developing proteinuria when being treated with penicillamine have been studied. In 5 the proteinuria was mild and resolved rapidly. Eleven of the remaining patients have undergone renal biopsy. One was found to have amyloidosis, and in the other 10 there was evidence of an immune complex type of injury, manifested by a granular immunoglobulin deposition within glomerular capillary walls associated with subepithelial deposits, found on electron microscopy. The proteinuria associated with this was mild (mean 2.6 g per 24 h) and occurred on average some eight months after commencing therapy (range 6 weeks to 60 months).

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • ADAMS DA, GOLDMAN R, MAXWELL MH, LATTA H. NEPHROTIC SYNDROME ASSOCIATED WITH PENICILLAMINE THERAPY OF WILSON'S DISEASE. Am J Med. 1964 Feb;36:330–336. [PubMed]
  • Clarkson AR, Morton JB, Cash JD. Urinary fibrin-fibrinogen degradation poducts after renal homotransplantation. Lancet. 1970 Dec 12;2(7685):1220–1223. [PubMed]
  • DIXON FJ, FELDMAN JD, VAZQUEZ JJ. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961 May 1;113:899–920. [PMC free article] [PubMed]
  • GOLDBERG A, SMITH JA, LOCHHEAD AC. Treatment of lead-poisoning with oral penicillamine. Br Med J. 1963 May 11;1(5340):1270–1275. [PMC free article] [PubMed]
  • Golding JR, Wilson JV, Day AT. Observations on the treatment of rheumatoid disease with penicillamine. Postgrad Med J. 1970 Oct;46(540):599–605. [PMC free article] [PubMed]
  • Hayslett JP, Bensch KG, Kashgarian M, Rosenberg LE. Focal glomerulitis due to penicillamine. Lab Invest. 1968 Oct;19(4):376–381. [PubMed]
  • Jaffe IA. The effect of penicillamine on the laboratory parameters in rheumatoid arthritis. Arthritis Rheum. 1965 Dec;8(6):1064–1079. [PubMed]
  • Luke RG, Briggs JD, Fell GS, Kennedy AC. Proteinuria associated with D-penicillamine therapy of cystinuria. J Urol. 1968 Feb;99(2):207–210. [PubMed]
  • Rosenberg LE, Hayslett JP. Nephrotoxic effects of penicillamine in cystinuria. JAMA. 1967 Aug 28;201(9):698–699. [PubMed]
  • Stephens AD, Watts RW. The treatment of cystinuria with N-acetyl-D-penicillamine, a comparison with the results of D-penicillamine treatment. Q J Med. 1971 Jul;40(159):355–370. [PubMed]
  • Virella G. Degradation of IgG3 monoclonal proteins during storage and in the presence of a thiol (DL-penicillamine). Experientia. 1971 Jan 15;27(1):94–96. [PubMed]
  • WALSHE JM. Wilson's disease; new oral therapy. Lancet. 1956 Jan 7;270(6906):25–26. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press